0001104659-22-000917.txt : 20220104
0001104659-22-000917.hdr.sgml : 20220104
20220104161614
ACCESSION NUMBER: 0001104659-22-000917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Durso Jerome Benedict
CENTRAL INDEX KEY: 0001698665
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 22506119
MAIL ADDRESS:
STREET 1: 840 PARK AVE
CITY: HOBOKEN
STATE: NJ
ZIP: 07030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tm221409d2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-31
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001698665
Durso Jerome Benedict
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
1
1
0
0
President & CEO
Common Stock
2021-12-31
4
F
0
5607
16.29
D
75957
D
Common Stock
2022-01-01
4
F
0
334
16.29
D
75623
D
Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.
/s/ Rocco Venezia, as attorney-in-fact
2022-01-04